Pfizer Inc. (PFE) has announced the adoption of an amended and restated 2019 Stock Plan, effective as of the date of the 2024 Annual Meeting of Shareholders. The plan, which was first established on April 25, 2019, has been updated to increase the number of shares authorized for grant by 320 million, in addition to the shares remaining available as of the effective date. This amendment aims to provide incentives to employees and non-employee directors by offering increased common stock ownership through various stock options and awards. The plan allows for the issuance of incentive stock options, non-qualified stock options, and other equity-based awards, with provisions to ensure compliance with tax and regulatory requirements. The Board of Directors has the authority to...Show More

Pfizer Inc. (PFE) has announced the adoption of an amended and restated 2019 Stock Plan, effective as of the date of the 2024 Annual Meeting of Shareholders. The plan, which was first established on April 25, 2019, has been updated to increase the number of shares authorized for grant by 320 million, in addition to the shares remaining available as of the effective date. This amendment aims to provide incentives to employees and non-employee directors by offering increased common stock ownership through various stock options and awards. The plan allows for the issuance of incentive stock options, non-qualified stock options, and other equity-based awards, with provisions to ensure compliance with tax and regulatory requirements. The Board of Directors has the authority to amend or terminate the plan, with shareholder approval required for certain changes. The plan is designed to attract, retain, and motivate talent, aligning their interests with long-term shareholder value. The announcement details the plan's administration, eligibility, and the various types of awards available, including performance-based awards and provisions for change in control scenarios.